SCHEMBL25075159

SCHEMBL25075159

Cc1c(Cl)cnn(COCC[Si](C)(C)C)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.40
HTT P42858 9/20 0.40
NPSR1 Q6W5P4 7/20 0.40
RAB9A P51151 6/20 0.40
LMNA P02545 6/20 0.40
NPC1 O15118 5/20 0.40
S1PR2 O95136 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
S1PR4 O95977 2/20 0.40
S1PR1 P21453 2/20 0.40
HCRTR1 O43613 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
TLR9 Q9NR96 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21521058 0.87 HTT (0.49) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL25616986 0.85 NPC1 (0.34) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL21519281 0.84 ALDH1A1 (0.40) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL25048792 0.82 DGAT1 (0.34) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL21519266 0.81 ALDH1A1 (0.40) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL31104413 0.79 HTT (0.36) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL25616992 0.78 RAB9A (0.40) ALDH1A1RAB9ALMNANPC1PKM
Hydrochloric Acid SCHEMBL31618032 0.77 ALDH1A1 (0.31) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL31104128 0.76 NPC1 (0.35) ALDH1A1HTTNPSR1RAB9ALMNA
SCHEMBL21519273 0.75 NPC1 (0.50) ALDH1A1HTTNPSR1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE 2023-06-22 US disclosed
WO-2023020479-A1 PARP7 INHIBITOR AND APPLICATION THEREOF 重庆华森制药股份有限公司 2023-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 ALDH1A1 1033/4885HTT 4101/4885NPSR1 4185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.